Status:
COMPLETED
Self-Managed Intervention for Anxiety in Parkinson's Disease
Lead Sponsor:
Virginia Commonwealth University
Conditions:
Parkinson Disease
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A mixed methods randomized controlled feasibility and acceptability study will be conducted to determine the effects of a self-managed, focused breathing intervention on anxiety in persons who have be...
Detailed Description
This study is being conducted to determine the feasibility and acceptability of using focused breathing as a self managed, non-pharmacologic intervention for anxiety experienced by those with Parkinso...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Parkinson's disease
- Hoehn \& Yahr I, II, \& III
- Self report or clinical diagnosis of anxiety
- Ability to speak and read English
Exclusion
- Montreal Cognitive Assessment scores less than 26, indicating cognitive impairment
- Persons under the age of 18 are excluded from this study
Key Trial Info
Start Date :
March 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03859180
Start Date
March 15 2019
End Date
November 11 2019
Last Update
January 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298